ASCO 2019 | Breast Cancer: paclitaxel alone or combined with cobimetinib

Adam Brufsky, MD, PhD, of the University of Pittsburgh Medical Center, Pittsburgh, PA, discusses the use of paclitaxel alone or combined with cobimetinib for the treatment of breast cancer which was assessed in the COLET trial (NCT02322814). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.